| Cassandra Jane Legarde, CCC-SLP | |
|
965 West Rd, Mountain Home, AR 72653-4544 | |
| (870) 425-1288 | |
| Not Available |
| Full Name | Cassandra Jane Legarde |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 965 West Rd, Mountain Home, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174133193 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 3411 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Cassandra Jane Legarde, CCC-SLP 102 Lannys Ln, Mountain Home, AR 72653-5287 Ph: (870) 405-2440 | Cassandra Jane Legarde, CCC-SLP 965 West Rd, Mountain Home, AR 72653-4544 Ph: (870) 425-1288 |
News Archive
A new paper published online in the Annals of the American Thoracic Society describes a nimble, pragmatic and rigorous multicenter clinical trial design to meet urgent community needs in the face of the COVID-19 pandemic.
The conformance of genetic characteristics is essential for the long-term function after kidney transplantation. This is the central result of a recent study in the top journal "The Lancet" with more than 500 patients after kidney transplantation, conducted by a global consortium led by Rainer Oberbauer and his colleagues Roman Reindl-Schwaighofer and Andreas Heinzel from the Division of Nephrology and Dialysis at MedUni Vienna.
Today, the Global Virus Network, a conglomerate of 52 "Centers of Excellence" and 9 Affiliates in 32 countries, which catalyzes collaborative research into diseases caused by every class of virus in humans and animals, announced the Wyss Institute for Biologically Inspired Engineering at Harvard University as a new Center of Excellence.
Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced positive results from two multicenter, double-blind, randomized, placebo-controlled Phase 3 clinical studies evaluating low-dose mesylate salt of paroxetine (LDMP; 7.5 mg/day) for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause.
› Verified 2 days ago
Jordan Philip Thrasher, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3117 Partipilo St, Mountain Home, AR 72653 Phone: 501-206-4555 | |
Sarah Dewey, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1310 Bradley Dr, Mountain Home, AR 72653 Phone: 501-733-9845 | |
Bernadette Augustine Godwin, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 18 County Road 458, Mountain Home, AR 72653 Phone: 870-425-5252 | |
Mollie Virginia Jane Breckenridge, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 230 Highway 5 N Ste 10, Mountain Home, AR 72653 Phone: 870-404-0270 | |
Mrs. Sarah Ellen Blagg, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2203 Russell Ln, Mountain Home, AR 72653 Phone: 870-404-5870 Fax: 870-430-5934 | |
Rebecca M Bradley, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 18 County Road 458, Mountain Home, AR 72653 Phone: 870-425-5252 | |
Riley Jean Gottschalk, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 347 Hwy 62 East, College Plaza, Mountain Home, AR 72653 Phone: 870-701-5089 |